Hematopoietic stem-cell transplantation from unrelated donors in elderly patients (age>55 years) with hematologic malignancies: older age is no longer a contraindication when using reduced intensity conditioning
Open Access
- 4 November 2004
- journal article
- research article
- Published by Springer Nature in Leukemia
- Vol. 19 (1) , 7-12
- https://doi.org/10.1038/sj.leu.2403591
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donorsBlood, 2004
- Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantationBlood, 2004
- HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignanciesBlood, 2003
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationBlood, 2001
- Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapyBritish Journal of Haematology, 2000
- Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experienceBone Marrow Transplantation, 2000
- Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor ProgramNew England Journal of Medicine, 1993
- Regimen-related toxicity in patients undergoing bone marrow transplantation.Journal of Clinical Oncology, 1988
- Bone-Marrow TransplantationNew England Journal of Medicine, 1975
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958